The presence of insomnia and depression contributes to the acceptance of an initial treatment trial of continuous positive airway pressure therapy in patients with obstructive sleep apnea
- PMID: 33411189
- DOI: 10.1007/s11325-020-02266-z
The presence of insomnia and depression contributes to the acceptance of an initial treatment trial of continuous positive airway pressure therapy in patients with obstructive sleep apnea
Abstract
The presence of comorbid insomnia and sleep apnea (COMISA) reduces the initial acceptance of continuous positive airway pressure (CPAP) therapy in 39-58% of patients with obstructive sleep apnea (OSA). Depressive disorders are reported in 5 to 63% of patients with OSA. Here we studied the co-occurrence of depression and insomnia in OSA patients and its impact on treatment acceptance in a real-life controlled trial.
Methods: In this prospective, uncontrolled study, participants were recruited from January to December 2018, among adult patients who visited our sleep lab. Participants underwent polysomnography study and completed the Epworth Sleepiness Scale (ESS), Athens Insomnia Scale (AIS), and Zung Depression Rating Scale (ZDRS). All subjects were categorized into 8 groups: no OSA/no depression (apnea-hypopnea index [AHI] < 5/h, n = 34), mild OSA/no depression (AHI = 5-14/h, n = 22), moderate OSA/no depression (AHI = 15-29/h, n = 44), severe OSA/no depression (AHI ≥ 30/h, n = 45), no OSA/mild depression (AHI < 5/h, n = 31), mild OSA/mild depression (AHI = 5-14/h, n = 24), moderate OSA/mild depression (AHI = 15-29/h, n = 31), and severe OSA/mild depression (AHI ≥ 30/h, n = 40).
Results: Over the one-year period, 272 participants (200 men, mean age 52.9 ± 13.0 years, BMI 33.6 ± 7.2 kg/m2) were enrolled. When the above 8 groups were subcategorized into the presence or absence of insomnia, we found no differences in CPAP trial acceptance between subgroups except in patients from the mild depression/severe OSA/insomnia subgroup who denied CPAP therapy more frequently (chi-squared test p = 0.016). We found, with a moderate efficiency indicated by the ROC curve, that patients with AHI > 15/h, AIS ≥ 11, and ZDRS > 44 were more likely to refuse an initial trial of CPAP treatment because of COMISA and depression (ROC curve area = 0.710, p = 0.049).
Conclusion: This study demonstrates that it is important to recognize a depressive mood disorder in patients with moderate/severe OSA and COMISA as the coexistence of these comorbidities impairs the rate of initial acceptance of CPAP treatment. Additionally, our study suggests the cut-off values from the AIS and ZDRS questionnaires to help lead clinicians to an early diagnostic evaluation of COMISA patients for the presence of depressive mood disorder.
Keywords: Continuous positive airway pressure; Depression; Insomnia; Obstructive sleep apnea; Zung scale of depression.
© 2021. Springer Nature Switzerland AG.
Similar articles
-
Cognitive and behavioral therapy for insomnia increases the use of continuous positive airway pressure therapy in obstructive sleep apnea participants with comorbid insomnia: a randomized clinical trial.Sleep. 2019 Dec 24;42(12):zsz178. doi: 10.1093/sleep/zsz178. Sleep. 2019. PMID: 31403168 Clinical Trial.
-
Polysomnography in patients with obstructive sleep apnea: an evidence-based analysis.Ont Health Technol Assess Ser. 2006;6(13):1-38. Epub 2006 Jun 1. Ont Health Technol Assess Ser. 2006. PMID: 23074483 Free PMC article.
-
Comorbid insomnia and sleep apnea in Veterans with post-traumatic stress disorder.Sleep Breath. 2018 Mar;22(1):23-31. doi: 10.1007/s11325-017-1618-y. Epub 2018 Jan 10. Sleep Breath. 2018. PMID: 29330769
-
Continuous Positive Airway Pressure vs Mandibular Advancement Devices in the Treatment of Obstructive Sleep Apnea: An Updated Systematic Review and Meta-Analysis.Cureus. 2022 Jan 31;14(1):e21759. doi: 10.7759/cureus.21759. eCollection 2022 Jan. Cureus. 2022. PMID: 35251830 Free PMC article. Review.
-
Comorbid Insomnia and Obstructive Sleep Apnea (COMISA): Current Concepts of Patient Management.Int J Environ Res Public Health. 2021 Sep 1;18(17):9248. doi: 10.3390/ijerph18179248. Int J Environ Res Public Health. 2021. PMID: 34501836 Free PMC article. Review.
Cited by
-
Insomnia affects patient-reported outcome in sleep apnea treated with hypoglossal nerve stimulation.Laryngoscope Investig Otolaryngol. 2022 May 24;7(3):877-884. doi: 10.1002/lio2.761. eCollection 2022 Jun. Laryngoscope Investig Otolaryngol. 2022. PMID: 35734047 Free PMC article.
-
Worldwide prevalence and associated risk factors of obstructive sleep apnea: a meta-analysis and meta-regression.Sleep Breath. 2023 Dec;27(6):2083-2109. doi: 10.1007/s11325-023-02810-7. Epub 2023 Mar 27. Sleep Breath. 2023. PMID: 36971971 Review.
-
[Health-Related Quality of Life and Therapeutic Adherence to Continuous Positive Airway Pressure (CPAP) in Patients with Obstructive Sleep Apnea (OSA)].Open Respir Arch. 2022 Oct 3;5(1):100214. doi: 10.1016/j.opresp.2022.100214. eCollection 2023 Jan-Mar. Open Respir Arch. 2022. PMID: 37497254 Free PMC article. Spanish.
-
Cardiovascular risk associated with co-morbid insomnia and sleep apnoea (COMISA) in type 2 diabetics.Sleep Sci. 2022 Jan-Mar;15(Spec 1):184-194. doi: 10.5935/1984-0063.20220018. Sleep Sci. 2022. PMID: 35273765 Free PMC article.
-
Risk of Cardiovascular Disease in Apnoeic Individuals: Role of Comorbid Insomnia Disorder.Life (Basel). 2022 Jun 23;12(7):944. doi: 10.3390/life12070944. Life (Basel). 2022. PMID: 35888034 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous